Skip to main content
Clinical Trials/NL-OMON26807
NL-OMON26807
Not Yet Recruiting
N/A

Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after treatment for breast cancer.

Z Leuven0 sites50 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patients treated for breast cancer and chronic pain (> 3 months) at the breast region
Sponsor
Z Leuven
Enrollment
50
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Z Leuven

Eligibility Criteria

Inclusion Criteria

  • women after breast cancer with unilateral axillary lymph node dissection or sentinel node biopsy; mastectomy (with or without autologous reconstruction) or wide excision of the tumour
  • \- adjuvant chemotherapy and/or radiotherapy finished for at least 3 months
  • \- Pain at the breast region for at least 3 months

Exclusion Criteria

  • \- Patients with metastasis and patients who cannot participate during the entire study or patients who are mentally or physically not able to participate in the study are excluded
  • \- Cases were no injection is possible in the pectoral muscle (e.g. reconstruction with a tissue expander) are excluded as well.

Outcomes

Primary Outcomes

Not specified

Similar Trials